Clinical Trials Browser

OTHER × Glioma × Vorinostat × Clear all

NCT01110876 2021-08-25

Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM)

Phase 1/2 Terminated

21 enrolled 8 charts

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma

NCT01738646 2017-03-06

Ph II SAHA and Bevacizumab for Recurrent Malignant Glioma Patients

Phase 2 Completed

48 enrolled 10 charts

Brain Neoplasms, Glioblastoma, Glioma